Oncology Analytics, a U.S.-based health technology-enabled service company, closed $21 million in Series B funding round.

The round was led by U.S.-based private equity firm Oak HC/FT joined by new investor McKesson Ventures along with returning investors Blue Cross Blue Shield Venture Partners and Sandbox Advantage Fund.

Oncology Analytics intends to use the funds to expand its oncology benefits management capabilities and accelerate strategic investments in data analytics, data science, and innovative digital health technologies.

Oncology Analytics also announced that healthcare investor Oak HC/FT will join its board of directors.